Ocimum Biosolutions B.V. Introduces Affymetrix Services in Europe

Launches Expanded Range of Genomics Services from Its Netherlands Facility
IJSSELSTEIN, Netherlands--(Business Wire)--
In line with its strategic objective to build a global network of service
centers in close proximity to leading genomics researchers, Ocimum Biosolutions
B.V. today announced the launch of genomic services on Affymetrix platform from
Europe. Initially Ocimum will service Gene Expression studies on the Affymetrix
platform from its facility at IJsselstein, The Netherlands. Within a couple of
months, it will launch the entire bouquet of services from its IJsselstein
facility.

"Ocimum-Gene Logic is focused on providing high quality, validated and industry
leading services to our clients worldwide. With the introduction of Affymetrix
based genomics services in Europe, we are now available at the doorsteps of
leading lifescience companies and research centers in Europe. Having replicated
the same protocols which are used in our GLP compliant Gaithersburg facility,
our European center would also now generate and analyze genomic and gene
expression data with the same quality and attention to detail that make us the
partner of choice for two-thirds of the top 25 pharmaceutical/biotech companies
and research centers," says Anu Acharya, CEO, Ocimum Biosolutions and Gene
Logic.

"We share a long-standing and deep relationship with Ocimum-Gene Logic," said
Kevin King, President and CEO of Affymetrix. "Gene Logic has been an Authorized
Service Provider for Affymetrix for more than a decade, providing genomic
services on the Affymetrix platform from its Gaithersburg lab, which is one of
the largest commercial microarray facilities in the world. We are very proud to
be associated with this exciting expansion."

For more information, please visit www.genelogic.com/services or e-mail to
europe@ocimumbio.com.

About Ocimum Biosolutions

Ocimum Biosolutions is a leading integrated genomics company providing
comprehensive genomic reference databases, life science lab information
management solutions, GLP-compliant microarray services and essential research
consumables. Over 2/3rd of the top 25 pharma companies, leading research
institutes and emerging biotech companies worldwide have chosen us as their
preferred outsourcing partner and utilize our expertise for understanding
underlying mechanisms of diseases, discovery and prioritization of gene targets
and biomarkers.

We are a preferred outsourcing partner for providing integrated biorepository
and genomic services for several global pharmaceutical companies. Our global
infrastructure, standardized procedures, capacity, expertise and highly skilled
staff support drug development programs from pre-clinical target development and
toxicogenomic assessment to clinical biomarker identification and patient
stratification. In creating the world's largest commercial gene expression
databases - BioExpress and ToxExpress, we have developed expertise and
capabilities that are unparalleled in the genomic services industry. We provide
multiple GLP-compliant platforms for gene expression and SNP genotyping data
generation. We also provide full biorepository and genomic services support for
the Genetic Alliance, which is an umbrella organization representing ~600
genetic advocacy groups. Besides providing the physical infrastructure for
storing thousands of biological samples, we provide services to assist sample
accrual, IRB approvals, CRO training, sample collection, clinical data capture
and management.

About Affymetrix

Affymetrix GeneChip® microarray technology is the industry-standard tool for
analyzing complex genetic information. After inventing microarray technology in
the late 1980s, Affymetrix scientists have been dedicated to developing
innovative products that provide researchers with a more complete view of the
genome. These products continue to accelerate genetic research. They enable
scientists to develop diagnostics which may support the tailoring of treatments
for patients by identifying and measuring the genetic information associated
with complex diseases.

Today, Affymetrix technology is used by the world`s top pharmaceutical,
diagnostic and biotechnology companies, as well as leading academic, government
and not-for-profit research institutes. More than 1,800 systems have been
shipped around the world and more than 16,000 peer-reviewed papers have been
published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing
facilities in Cleveland, Ohio, and Singapore. The company has about 1,100
employees worldwide and maintains sales and distribution operations across
Europe and Asia. For more information about Affymetrix, please visit the
company`s website at www.affymetrix.com.

Ocimum Biosolutions
Ms. Dhanya Menon, +91-40-66627200
pr@ocimumbio.com

Copyright Business Wire 2009